Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 Months

Summary

This study is a multi-center, randomized, double-blind Phase III Clinical trial. The purpose of this study is to assess the immunogenicity and safety of the quadrivalent cell culture-derived influenza vaccine compare to the trivalent cell culture-derived influenza vaccine in children aged 6\~35 months.

Timeline

Start

2016-10

Primary completion

2017-03

Completion

2017-06

Drugs

Indications